SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 31 | 30 | −1 |
| Shares | 3.51M | 7.74M | +4.22M (+120.2%) |
| Value | $3.72M | $7.82M | +$4.09M (+109.9%) |
New holders (7)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 4,832,368 | $4.88M | 0.36% |
| Prosperity Financial Group, Inc. | 25,385 | $25.6K | 0.02% |
| Mariner, LLC | 25,257 | $25.5K | 0.00% |
| Cantor Fitzgerald, L. P. | 24,750 | $25.0K | 0.01% |
| Citadel Advisors LLC | 19,718 | $19.9K | 0.00% |
| Brooklyn FI, LLC | 11,178 | $11.3K | 0.00% |
| FMR LLC | 1 | $1 | 0.00% |
Sold out (8)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Armistice Capital, LLC | 820,000 | $869.2K |
| Group One Trading, L.P. | 186,355 | $197.5K |
| Bank of New York Mellon Corp | 84,665 | $89.7K |
| Renaissance Technologies LLC | 50,400 | $53.0K |
| Engineers Gate Manager LP | 16,857 | $17.9K |
| Two Sigma Securities, LLC | 15,304 | $16.2K |
| Millennium Management LLC | 11,239 | $11.9K |
| Bank of America Corp | 42 | $44 |